AKT1 and diffuse large B-cell lymphoma: Previous studies have reported that mutations affecting residues M1 (R19-L27) in diffuse large B-cell lymphoma (DLBCL) lead to the loss of the AKT recognition motif or abnormal nuclear localization of FOXO1, correlating with poorer prognoses [19].